Adopt Technology Solutions To Innovate and Streamline Your Regulatory Services

By Michelle Gyzen, Senior Director, Regulatory Affairs and Drug Development Solutions (RADDS) and Jens-Olaf Vanggaard, Senior Director, Global Safety, Regulatory and Quality (SRQ) Solutions

Pharmaceutical regulation is rapidly expanding to meet global demand for innovative drug products. As a result, sponsors must strive to walk the fine line between maintaining compliance and minimizing the burden for their staff. As regulations and standards increase in quantity and complexity around the world, workloads continue to mount. In the information and data domain, more information is now required for submission to health authorities. To adapt to the regulatory complexity inherent to global drug campaigns, both vendors and sponsors are implementing new technology to augment the regulatory workflow, including automation and artificial intelligence (AI).

In this climate, a virtually enabled model is increasingly the standard. To better support this, more companies are turning to development and outsourcing partners for assistance. No matter where you are in your drug development journey and how you plan to approach the process, familiarize yourself with the regulatory landscape and technologies available to augment your staff’s workload and ensure highly efficient processes. Download the full white paper to learn more about the solutions available to you.